Visigen Biotechnologies Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

Visigen Biotechnologies General Information

Description

Operator of a biotechnology company intended to develop a new regenerative science and molecular diagnostic process that will be used to sequence individual human genomes. The company provides a biomolecule labeling product and sequencing system platform that can be used for single-molecule genetic analysis and to label DNA, RNA, or oligos with a fluorescent dye for use in various applications.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2575 West Bellfort
  • Suite 250
  • Houston, TX 77054-9816
  • United States
+1 (713)
Primary Industry
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 2575 West Bellfort
  • Suite 250
  • Houston, TX 77054-9816
  • United States
+1 (713)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Visigen Biotechnologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Visigen Biotechnologies‘s full profile, request access.

Request a free trial

Visigen Biotechnologies Patents

Visigen Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2009105077-A2 Methods for preparing modified biomolecules, modified biomolecules and methods for using same Inactive 21-Feb-2008
WO-2009105077-A3 Methods for preparing modified biomolecules, modified biomolecules and methods for using same Inactive 21-Feb-2008
WO-2009014613-A2 An automated synthesis or sequencing apparatus and method for making and using same Inactive 20-Jul-2007
WO-2009014613-A3 An automated synthesis or sequencing apparatus and method for making and using same Inactive 20-Jul-2007
WO-2009014614-A2 Method and apparatus for moving stage detection of single molecular events Inactive 20-Jul-2007 G01N21/648
To view Visigen Biotechnologies’s complete patent history, request access »

Visigen Biotechnologies Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Visigen Biotechnologies‘s full profile, request access.

Request a free trial

Visigen Biotechnologies FAQs

  • When was Visigen Biotechnologies founded?

    Visigen Biotechnologies was founded in 2000.

  • Where is Visigen Biotechnologies headquartered?

    Visigen Biotechnologies is headquartered in Houston, TX.

  • What industry is Visigen Biotechnologies in?

    Visigen Biotechnologies’s primary industry is Biotechnology.

  • Is Visigen Biotechnologies a private or public company?

    Visigen Biotechnologies is a Private company.

  • What is the current valuation of Visigen Biotechnologies?

    The current valuation of Visigen Biotechnologies is .

  • What is Visigen Biotechnologies’s current revenue?

    The current revenue for Visigen Biotechnologies is .

  • Who are Visigen Biotechnologies’s investors?

    Applied Biosystems, SeqWright, and University of Houston have invested in Visigen Biotechnologies.

  • When was Visigen Biotechnologies acquired?

    Visigen Biotechnologies was acquired on 21-Dec-2008.

  • Who acquired Visigen Biotechnologies?

    Visigen Biotechnologies was acquired by Invitrogen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process